WIKA India Launches 'Re-Inventing Hygiene' for Pharma Standards

WIKA Instruments India, the world's leading precision measurement solution provider, has introduced its newest strategic movement titled 'Re-Inventing Hygiene' to revolutionize the standard of hygiene in the pharmaceutical sector.

India and Uzbekistan to Boost Pharma Ties for Stronger Trade Links

Building on recent efforts to enhance healthcare and pharmaceutical cooperation, India and Uzbekistan are eager to explore new areas of collaboration following a virtual session.

AUTOMA+ 2025: Smart Pharma Vision for Tomorrow

The Pharmaceutical Automation and Digitalisation Congress (AUTOMA+) 2025 welcomes delegates to be a part of its 5th anniversary in Vösendorf, Austria on 24-25 November. This edition focuses on AI-powered pharma, robotics and smart digital solutions.

DCC Approves Amendments to Stem Cell & Gene Therapy Licensing Rules

Drugs Consultative Committee (DCC) has sanctioned the modification of the Drugs Rules, 1945, so that products derived from stem cells and gene therapy products can be encompassed in securing a manufacturing license.

Emcure Launches Emcure Wellness to Expand Pharma Portfolio

Emcure Pharmaceuticals has incorporated a new wholly-owned subsidiary, Emcure Wellness Private Limited, indicating a strategic direction towards diversifying within India's growing healthcare and wellness sector. The new subsidiary was formed on...

J&J Seeks EMA Nod to Expand Akeega Use in Prostate Cancer Cases

Janssen-Cilag International NV, which is a Johnson & Johnson subsidiary, submitted an extension of indication application to the European Medicines Agency (EMA) for the approval of AKEEGA

India Fast Emerging as Global Powerhouse in Pharma & MedTech R&D

According to Lok Sabha Speaker Om Birla, India is quickly establishing itself as a global hub for pharmaceuticals and medical research. In New Delhi, Birla said this at the 7th International Conference of the Innovative Physicians Forum...

Advanced Prostate Cancer Therapy Trial Gains Backing from RedHill Biopharma

A substantial milestone in the therapeutic market of advanced prostate cancer, RedHill Biopharma Ltd. has launched the patient enrollment in a larger Phase 2 study focusing on metastatic castrate-resistant prostate cancer (mCRPC). The project indicat

Kerala on High Alert as Suspected Nipah Cases Raise Public Health Concerns

Kerala has declared a health alert in three districts, Kozhikode, Malappuram, and Palakkad, in view of two suspected cases of the Nipah virus. The Health department of Kerala made a note of the two patients who presented with Nipah-like symptoms...

Lupin Expands US Market Presence with New Complex Generic Nasal Spray

In an aim to expand in the high-value complex generics, Indian pharma major Lupin has introduced Ipratropium Bromide Nasal Solution to the United States. The product is the 0.03 percent and 0.06 percent generic equivalent of Atrovent Nasal Spray, whi

on the deck


Most Viewed

Editor's Guest


© 2025 India Pharma Outlook. All Rights Reserved.